|
|
Volumn 26, Issue 8, 2008, Pages 839-840
|
|
EGFR inhibitors embrace KRAS
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BIOLOGICAL MARKER;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;
PANITUMUMAB;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CELL PROLIFERATION;
CLINICAL STUDY;
COLORECTAL CANCER;
GENE;
GENE MUTATION;
GENE OVEREXPRESSION;
KRAS GENE;
METASTASIS;
NOTE;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
ANTINEOPLASTIC AGENTS;
COLORECTAL NEOPLASMS;
GENES, RAS;
HUMANS;
MUTATION;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 49449107381
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0808-839 Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
